|Mr. Paul R. Gudonis||Chairman, CEO & Pres||N/A||N/A||1955|
|Ms. Davie Mendelsohn RN||VP of Sales & Clinical Services||N/A||N/A||1954|
|Mr. Jonathan Naft CPO||VP & GM||N/A||N/A||1965|
|Mr. Ralph A. Goldwasser||CFO & Principal Accounting Officer||N/A||N/A||1948|
|Mr. Clifford J. Conneighton||Chief Marketing Officer||N/A||N/A||1950|
Myomo, Inc., a commercial stage medical robotics Company, provides expanded mobility solutions for patients suffering from neurological disorders and upper limb paralysis in the United States. The company develops and markets MyoPro, a myoelectric elbow/wrist/hand orthosis that supports an impaired hands and arms of individuals due to a brachial plexus injury, stroke, spinal cord injury, traumatic brain injury, amyotrophic lateral sclerosis, multiple sclerosis, and other upper limb neuromuscular deficits. Myomo, Inc. and is headquartered in Cambridge, Massachusetts.
Myomo, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.